Operators and patients to benefit from Karl 100
Pictured at the Royal Free Hospital are head of nuclear medicine physics Daniel McCool, Imaging Equipment Limited sales consultant Richard Welsh, chief nuclear medicine technologist Amy Pritchard, PET/CT lead technologist Firdousa Hassan and Tema Synergie European sales manager Lorenzo Mattioli.
Royal Free Hospital, London, has installed a Tema Synergie Karl 100 PET infusion system in its nuclear medicine physics department. Supplied by Imaging Equipment Limited, the Karl 100 was selected for its 90 per cent operator dose reduction, improved workflow and better management of FDG. Patient benefits include never being connected to the multi-dose mother vial with no risk of patient-to-patient contamination.
Head of nuclear medicine Daniel McCool said: “We really like the aspects the Karl 100 offers us safety for both our operators and patients.”
See this report on page 14 of the April 2014 issue of RAD Magazine.
